These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24018262)

  • 1. Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.
    Guillard T; Cambau E; Chau F; Massias L; de Champs C; Fantin B
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5830-5. PubMed ID: 24018262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli.
    Machuca J; Ortiz M; Recacha E; Díaz-De-Alba P; Docobo-Perez F; Rodríguez-Martínez JM; Pascual Á
    J Antimicrob Chemother; 2016 Nov; 71(11):3066-3071. PubMed ID: 27494906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.
    Allou N; Cambau E; Massias L; Chau F; Fantin B
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4292-7. PubMed ID: 19635960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
    Lepeule R; Ruppé E; Le P; Massias L; Chau F; Nucci A; Lefort A; Fantin B
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1376-81. PubMed ID: 22214774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
    Vinué L; Corcoran MA; Hooper DC; Jacoby GA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inoculum effect of Escherichia coli expressing mcr-1 or not on colistin activity in a murine model of peritonitis.
    Fantin B; Poujade J; Grégoire N; Chau F; Roujansky A; Kieffer N; Berleur M; Couet W; Nordmann P
    Clin Microbiol Infect; 2019 Dec; 25(12):1563.e5-1563.e8. PubMed ID: 31494253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
    Rossi B; Soubirou JF; Chau F; Massias L; Dion S; Lepeule R; Fantin B; Lefort A
    Antimicrob Agents Chemother; 2016 Jan; 60(1):424-30. PubMed ID: 26525800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
    Tamang MD; Nam HM; Chae MH; Kim SR; Gurung M; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2012 Dec; 9(12):1057-63. PubMed ID: 23186547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of plasmid-mediated quinolone resistance genes in uropathogenic Escherichia coli isolated in a teaching hospital of northern Italy.
    Musumeci R; Rausa M; Giovannoni R; Cialdella A; Bramati S; Sibra B; Giltri G; Viganò F; Cocuzza CE
    Microb Drug Resist; 2012 Feb; 18(1):33-41. PubMed ID: 21711147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of ST131 Clone Producing Both ESBL CTX-M-15 and AAC(6')Ib-cr Among Ciprofloxacin-Resistant
    Alsharapy SA; Yanat B; Lopez-Cerero L; Nasher SS; Díaz-De-Alba P; Pascual Á; Rodríguez-Martínez JM; Touati A
    Microb Drug Resist; 2018 Dec; 24(10):1537-1542. PubMed ID: 29883247
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.
    Briales A; Rodríguez-Martínez JM; Velasco C; de Alba PD; Rodríguez-Baño J; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2012 May; 39(5):431-4. PubMed ID: 22365240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli.
    Vinué L; Hooper DC; Jacoby GA
    Int J Antimicrob Agents; 2018 Mar; 51(3):479-483. PubMed ID: 29360506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
    Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
    J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temocillin breakpoints in pyelonephritis: evaluation in a murine model due to ESBL-producing Escherichia coli clinical isolates.
    Alexandre K; Soares A; Chau F; Fantin B; Caron F; Etienne M
    J Antimicrob Chemother; 2019 May; 74(5):1323-1326. PubMed ID: 30689887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.
    Johnson JR; Porter SB; Thuras P; Johnson TJ; Price LB; Tchesnokova V; Sokurenko EV
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7132-5. PubMed ID: 26324269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu.
    Domínguez-Herrera J; Velasco C; Docobo-Pérez F; Rodríguez-Martínez JM; López-Rojas R; Briales A; Pichardo C; Díaz-de-Alba P; Rodríguez-Baño J; Pascual A; Pachón J
    J Antimicrob Chemother; 2013 Jul; 68(7):1609-15. PubMed ID: 23493313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugal transfer of PMQR from uropathogenic E.coli under high ciprofloxacin selection pressure generates gyrA mutation.
    Basu S; Mukherjee M
    Microb Pathog; 2019 Jul; 132():26-29. PubMed ID: 30999022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first report of the qnrB19, qnrS1 and aac(6´)-Ib-cr genes in urinary isolates of ciprofloxacin-resistant Escherichia coli in Brazil.
    Paiva MC; Nascimento AM; Camargo IL; Lima-Bittencourt CI; Nardi RM
    Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):687-9. PubMed ID: 22850962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
    Qiu H; Gong J; Butaye P; Lu G; Huang K; Zhu G; Zhang J; Hathcock T; Cheng D; Wang C
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29767711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of plasmid-mediated quinolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli.
    Yue L; Jiang HX; Liao XP; Liu JH; Li SJ; Chen XY; Chen CX; Lü DH; Liu YH
    Vet Microbiol; 2008 Dec; 132(3-4):414-20. PubMed ID: 18573620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.